Keita Kudo
Papers
1
Total Citations
2
H-Index
1
About
Keita Kudo is a leading figure in thoracic oncology, with a focused expertise in the management of thymic epithelial tumors and malignant pleural mesotheliomas. His most prominent contribution is his central role in authoring the 2024 "Medical Practice Guidelines for Lung Cancers," specifically Chapter 3, which provides the definitive, evidence-based recommendations for thymic tumors. This work, published in 2025, represents a critical synthesis of current evidence for clinicians navigating these rare and complex malignancies. While his citation count is currently modest, reflecting the recent publication of his landmark guideline, his work has an outsized impact on clinical practice in Japan, serving as the standard of care for thoracic surgeons and oncologists. Kudo’s research bridges the gap between rigorous evidence synthesis and practical, actionable clinical guidance, establishing him as a key architect of modern treatment protocols for thymic neoplasms.
Research Focus
Key Achievements
Top Papers
- 1